New CFO Gregg Gilbert Joins Mirador Therapeutics Team
Executive Leadership Transition at Mirador Therapeutics
In a significant move for Mirador Therapeutics, a pioneering precision medicine company, the organization recently announced the appointment of Gregg Gilbert as the new chief financial officer. With a robust background in biopharma equity research and investment banking spanning over 25 years, Gilbert is poised to play a crucial role in driving the company forward.
Insights from Leadership
The announcement was met with enthusiasm from Mirador’s Chairman and CEO, Mark C. McKenna, who expressed excitement about the timing of Gilbert's joining the team. “Since launching earlier this year with over $400 million in capital, the Mirador team is intent on rapidly expanding its portfolio,” McKenna stated, highlighting the strategic importance of bringing on board someone with Gilbert’s expertise at this pivotal moment.
Strategic Timing for Growth
McKenna further emphasized that Gilbert's extensive experience on Wall Street and his dual perspective as both a corporate leader and an investor will be invaluable for Mirador. His insights will guide the firm into its next growth phase, as it focuses on developing innovative therapies for immunology and inflammation (I&I).
Gilbert's Impressive Background
Before joining Mirador, Gilbert excelled as a managing director at Bank of America Securities, specializing in healthcare investment banking. His role involved advising life sciences companies at various development stages concerning capital-raising, mergers, and acquisitions. Moreover, Gilbert’s impressive reputation as a leading equity research analyst comes from his long tenure at Bank of America Merrill Lynch, where he was named to Institutional Investor’s All-America Research Team more than ten times.
Broadening His Leadership Horizon
With a notable career that also includes significant positions at Deutsche Bank and Truist Securities, Gilbert started as an analyst at Goldman Sachs. His well-rounded experiences in investment and analysis will enable him to contribute strategically to Mirador’s mission.
Commitment to Stakeholders
Gilbert is enthusiastic about his new role, stating, “Mirador is on an extraordinary path to creating value for shareholders and, ultimately, millions of people with immune-mediated and inflammatory diseases.” His dedication to making a meaningful impact through collaborative efforts within the team showcases his commitment to the company's values and vision.
About Mirador Therapeutics
Mirador Therapeutics is at the forefront of precision medicine, striving to develop pioneering therapeutics for immunology and inflammation. The company seeks to transform how precision medicine is perceived and utilized, leveraging its proprietary Mirador360 development engine. This advanced system focuses on cutting-edge biology, multi-modal data, and analytics, aimed at swiftly advancing new medications for individuals suffering from chronic immune-mediated inflammatory and fibrotic conditions.
Having launched in 2024, Mirador has amassed a remarkable $400 million from prominent life sciences investors. With a robust base situated in San Diego, CA, Mirador continues to push the boundaries of medicine to address critical health challenges. Individuals interested in learning more can visit www.miradortx.com and follow the company on LinkedIn.
Frequently Asked Questions
Who is the new CFO of Mirador Therapeutics?
The new CFO is Gregg Gilbert, who brings over 25 years of experience in the biopharma industry.
What is Gregg Gilbert's previous experience?
Before joining Mirador, Gilbert held key positions at Bank of America Securities and was instrumental in healthcare investment banking.
What is the focus of Mirador Therapeutics?
Mirador is focused on developing first-in-class or best-in-class therapies for immunology and inflammation.
How much capital has Mirador raised so far?
Mirador has raised over $400 million from leading life sciences investors.
Where is Mirador Therapeutics based?
The company is based in San Diego, California.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Snap's New Spectacles: A Bold Step Forward in Augmented Reality
- Logitech G and MOMO Team Up for Premium Racing Wheels
- Century Communities Earns Spotlight on Newsweek's Trustworthy List 2024
- Enhancing Fleet Safety with EROAD's New AI Dashcam Solution
- Investing Insights: Viking Therapeutics' Bullish Options Activity
- T2 Biosystems Faces Stock Challenges Amid New FDA Approvals
- Ponke Soars to New Heights After Joining Revolut Platform
- Fractal EMS and Gold Electronic Equipment Team Up for BMS
- Stoic Equity Partners Makes Key Acquisition in New Market
- Fractal EMS and Gold Electronic Team Up to Transform BMS
Recent Articles
- Bank3 Partners with Tyfone to Elevate Digital Banking Solutions
- Accenture Partners with Martian for Cutting-Edge AI Solutions
- Investigation Launched into Kewaunee Scientific Corp. Affairs
- Kaskela Law Investigates Corvus Pharmaceuticals for Investors
- Gavekal Research Alerts Investors of Potential S&P 500 Bear Market
- Kasisto Secures $90 Million Funding; Welcomes Don Layden
- Gabelli Dividend & Income Trust Achieves New Heights in Valuation
- Columbia Care's Stock Hits New Heights with $96.69
- Molina Healthcare's Generous Donation Aids Senior Care Workforce
- Steven Knerr Takes the Helm as CFO of Issuer Direct Corp
- Designer Brands' Stock Rating Holds Steady Despite Sales Dip
- TenantReports.com Transitions to TenantReportX for Growth
- Citi Analysts Project Federal Reserve Adjustments Ahead
- Investigation Announced for Darling Ingredients Inc. Investors
- Exane BNP Paribas Rates Intel Underperform Amid Strategic Shifts
- Investigation Launched into 4D Molecular Therapeutics' Decline
- New Guidance Aims to Protect Customers from Overdraft Fees
- Kaskela Law LLC Investigates Ocugen, Inc. Shareholders' Rights
- Understanding the Kaskela Law Investigation of Builders FirstSource
- Kaskela Law Investigates Protalix BioTherapeutics Shareholder Concerns
- Investigation Announced for Tyler Technologies Shareholders
- Investigation Launched by Kaskela Law on Amicus Therapeutics
- Orb Secures $25 Million to Innovate Software Billing Solutions
- Dr. Louise Mirrer Joins Moelis Board of Directors
- Exclaimer Welcomes Rob Singer as CEO to Propel Growth
- Impact BioMedical Inc. Successfully Completes IPO with Growth Prospects
- Adtran Launches New Distribution Center to Enhance Fiber Solutions
- Understanding Roth 401(k) Conversions: Is It Time for You?
- Purina and UC Davis Join Forces to Enhance Pet Health Research
- Kaskela Law Investigates Potential Issues at CBIZ, Inc.
- The Tech Titans' Plea for Nvidia GPUs: A Dinner to Remember
- Unlocking AI Opportunities: Free Bootcamp for Teens in Need
- Kaskela Law Investigates Inari Medical for Shareholder Claims
- Shervin Pishevar Takes Co-Chairman Role at Abra Amid Growth
- Dogecoin's Recent Stability: Analyzing the Trend and Future Moves
- Kaskela Law’s Investigation into Standex International Corp.
- Stryker Enhances Digital Capabilities with care.ai Acquisition
- Investors Affected by Vontier Corp. Share Price Drop
- Mullen Automotive Faces Stock Fluctuations Amid Changes
- Investigation Launched Into Decline of HOOKIPA Pharma Shares
- Global Maternity Health Insurance Trends & Future Insights
- Empowering Teens with Free AI Bootcamps in Silicon Valley
- Kaskela Law Investigates AGCO Corp. for Shareholder Rights
- Sodexo's Recent Stock Transactions: Overview and Key Details
- Empowering Miami Teens: Free AI Bootcamp Initiative
- Medidata Emerges as a Leader in Electronic Data Capture Solutions
- Idorsia Shares Exciting New Data on Sleep Treatment Research
- Firebolt Unveils Revolutionary Low Latency Cloud Data Warehouse
- RF Acquisition Corp. Announces New Redemption Price for Stockholders
- Empowering Honolulu Teens Through Free AI Education Initiative